References
1. Khorobrykh Т.V., Makhnach G.K., Volgin M.V., Khorobrykh V.V., Mishchenko N.P., Ivashchenko A.A., Loginov V.G., Yakubova E.V. Clinical and immunological correlations in COVID-19: experience of immunomodulatory therapy. Immunologiya. 2021; 42 (4): 376–84. DOI: https://doi.org/10.33029/0206-4952-2021-42-4-376-384 (in Russian)
2. Gudima G.O., Khaitov R.M., Kudlay D.A., Khaitov M.R. Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198–210. DOI: https://doi.org/10.33029/0206-4952-2021-42-3-198-210 (in Russian)
3. Parasher A. COVID-19: current understanding of its pathophysiology, clinical presentation and treatment. Postgrad. Med. J. 2021; 97 (1147): 312–20. DOI: https://doi.org/10.1136/postgradmedj-2020-138577
4. Soy M., Keser G., Atagündüz P., et al. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin. Rheumatol. 2020; 39: 2085–94. DOI: https://doi.org/10.1007/s10067-020-05190-5
5. Bivona G., Agnello L., Ciaccio M. Biomarkers for prognosis and treatment response in COVID-19 patients. Ann. Lab. Med. 2021; 41 (6): 540–8. DOI: https://doi.org/10.3343/alm.2021.41.6.540
6. Sizyakina L.P., Zakurskaya V.Yа., Skripkina N.A., Antonova E.A. Ferritin level as a predictor of COVID-19 severe course. Immunologiya. 2021; 42 (5): 518–25. DOI: https://doi.org/10.33029/0206-4952-2021-42-4-518-525 (in Russian)
7. Alizadehsani R., Alizadeh Sani Z., Behjati M., Roshanzamir Z., Hussain S., Abedini N., Hasanzadeh F., Khosravi A., Shoeibi A., Roshanzamir M., Moradnejad P., Nahavandi S., Khozeimeh F., Zare A., Panahiazar M., Acharya U.R., Islam S. Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients. J. Med. Virol. 2021; 93 (4): 2307–20. DOI: https://doi.org/10.1002/jmv.26699
8. Kim J.S., Lee J.Y., Yang J.W., Lee K.H., Effenberger M., Szpirt W., Kronbichler A., Shin J.I. Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics. 2021; 11 (1): 316–29. DOI: https://doi.org/10.7150/thno.49713
9. Temporary guidelines «Prevention, diagnosis and treatment of a new coronavirus infection (2019-nCoV)» of the Ministry of Health of the Russian Federation. Version 13.1 (09.11.2021) (in Russian)
10. Du P., Geng J., Wang F., Chen X., Huang Z., Wang Y. Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome. Int. J. Med. Sci. 2021; 18 (6): 1356–62. DOI: https://doi.org/10.7150/ijms.53564
11. Kalashnikova T.A., Yakovlev A.A., Sizyakina L.P. Characteristics of the immune status in patients with Crohn’s disease during therapy with Infliximab. Immunologiya. 2016; 37 (1): 22–5. DOI: https://doi.org/10.18821/0206-4952-2016-37-1-22–25 (in Russian)
12. Tanaka T., Narazaki M., Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspect. Biol. 2014; 6 (10): a016295. DOI: https://doi.org/10.1101/cshperspect.a016295
13. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today. 1990; 11 (12): 443–9.
14. Kumar M., Al Khodor S. Pathophysiology and treatment strategies for COVID-19. J. Transl. Med. 2020; 18 (1): 353. DOI: https://doi.org/10.1186/s12967-020-02520-8
15. Tharmarajah E., Buazon A., Patel V., Hannah J.R., Adas M., Allen V.B., Bechman K., Clarke B.D., Nagra D., Norton S., Russell M.D., Rutherford A.I., Yates M., Galloway J.B. IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression. J. Infect. 2021; 82 (5): 178–85. DOI: https://doi.org/10.1016/j.jinf.2021.03.008
16. Arkatkar T., Du S.W., Jacobs H.M., Dam E.M., Hou B., Buckner J.H., Rawlings D.J., Jackson S.W. B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity. J. Exp. Med. 2017; 214 (11): 3207–17. DOI: https://doi.org/10.1084/jem.20170580
17. Andreev I.V., Nechay K.O., Andreev A.I., Zubaryova A.P., Esaulova D.R., Alenova A.M., Nikolaeva I.A., Chernyavskaya O.P., Lomonosov K.S., Shul’zhenko A.E., Kurbacheva O.M., Latysheva E.A., Shartanova N.V., Nazarova E.V., Romanova L.V., Cherchenko N.G., Smirnov V.V., Averkov O.V., Martynov A.I., Vechorko V.I., Gudima G.O., Kudlay D.A., Khaitov M.R., Khaitov R.M. Post-vaccination and post-infection humoral immune response to the SARS-CoV-2 infection. Immunologiya. 2022; 43 (1): 18–32. DOI: https://doi.org/10.33029/0206-4952-2022-43-1-18-32 (in Russian)